Vaxcell-Bio Therapeutics stock price
박셀바이오KRX:323990 · KOSDAQ · HealthcareToday's signals · No active technical signal.
Signal details →Vaxcell-Bio Therapeutics last closed at ₩4,285 (-0.58%) on 2026-10-02. Listed on KOSDAQ. Trailing 12 months PER is -6.7×. Its overall grade ranks 292 of 306 stocks in Healthcare.
About this company
Vaxcell-Bio Therapeutics last closed at ₩4,285 (-0.58%) on 2026-10-02. Listed on KOSDAQ.
Details →Reported results
Position in sector
Healthcare · Overall F · 292/306
Valuation grade C+
Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- 한미약품Competitor
면역항암제·항암신약 개발 분야에서 비교되는 국내 제약/바이오 기업
- 유한양행Competitor
항암제 포함 혁신신약 개발을 하는 대표 국내 바이오/제약사
- GC녹십자Competitor
항암·면역 관련 바이오의약품 개발과 생산 역량을 가진 국내 대형 제약사
About Vaxcell-Bio Therapeutics
- What technical signals does Vaxcell-Bio Therapeutics (323990) have?
- Vaxcell-Bio Therapeutics current technical signals: no active technical signal.
- Is Vaxcell-Bio Therapeutics a cup-and-handle pattern?
- No. Vaxcell-Bio Therapeutics has no valid Cup signal right now.
- What published figures are available for Vaxcell-Bio Therapeutics?
- Market cap: KRW 99.66B. Trailing 12 months PER: -6.7×. Latest quarter PBR: 1.86×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Vaxcell-Bio Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.